TreeFrog Therapeutics is based in Lyon, France. It has raised $83M in total funding. Latest round: Series B.
TreeFrog Therapeutics is based in Lyon, France. TreeFrog Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for TreeFrog Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Bpifrance Large Venture, Leonard Green & Partners, Bristol-Myers Squibb, XAnge. 4 distinct backers are named across the disclosed rounds.
Every TreeFrog Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Lyon at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026